Semrush To Acquire Kompyte, Enhance Competitive Intelligence And Sales Enablement Capabilities
BOSTON–(BUSINESS WIRE)–Semrush (NYSE: SEMR), a leading online visibility management SaaS platform, today announces plans to…
BOSTON–(BUSINESS WIRE)–Semrush (NYSE: SEMR), a leading online visibility management SaaS platform, today announces plans to…
NEW YORK–(BUSINESS WIRE)–The Museum of American Finance will honor the achievements of financial leaders in…
New mobile network operator accelerates O-RAN as a Service through network automation with Anuta ATOM…
The Hartford now ranks highest in customer satisfaction with both the auto and home insurance…
Former AT&T and Starbucks Technology Leader Brings Extensive Transformative Software Experience at Global Enterprises DURANGO,…
JUNO BEACH, Fla.–(BUSINESS WIRE)–Florida Power & Light Company (FPL) today announced Cummins Inc. (NYSE: CMI)…
Machine Learning technology platform to be evaluated for potential use in predictive modeling for clinical…
Seasoned sales principals to focus on accelerating Quext’s buildout in multifamily proptech LUBBOCK, Texas–(BUSINESS WIRE)–Quext,…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed…
New appointment sets the company up for strong execution in 2022 and beyond AUSTIN, Texas–(BUSINESS…
Debt investment led by PSP Investments provides additional capital for further growth and innovation Houston,…
By Jochen Kern, Head of Sales & Marketing, micrometal GmbH There are numerous metal cutting…
Wednesday, March 2 at 10am ET / 3pm GMT / 4pm CET NIEL, Belgium, Feb….
ROCKVILLE, MD, Feb. 28, 2022 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company…
DURHAM, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Following successful completion of GEM-3 pivotal trial, Krystal is on track to file BLA for…
CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader…
DURHAM, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it…
Topline data from Phase 2 INSPIRE trial expected mid-year 2022 DEVON, Pa., Feb. 28, 2022…
Tonix is Developing TNX-2900 (Intranasal Potentiated Oxytocin) for the Treatment of Prader-Willi in Adolescents and…